Unity Biotechnology
Utility Patents

Last updated:

List of all Unity Biotechnology patents 17 in total

Status Patent
Grant
Utility: Methods of inhibiting pathological angiogenesis External link
Filling date: 8 Sep 2025 Issue date: 28 Sep 2021
Grant
Utility: Acylsulfonamide derivatives for treating senescence-associated diseases and disorders External link
Filling date: 8 Sep 2025 Issue date: 7 Sep 2021
Grant
Utility: Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer External link
Filling date: 8 Sep 2025 Issue date: 20 Apr 2021
Grant
Utility: Phospholidines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer External link
Filling date: 8 Sep 2025 Issue date: 18 Aug 2020
Grant
Utility: Conjugates that are configured for targeted delivery of therapeutic compounds to senescent cells External link
Filling date: 8 Sep 2025 Issue date: 18 Aug 2020
Grant
Utility: Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer External link
Filling date: 8 Sep 2025 Issue date: 21 Jul 2020
Grant
Utility: Acyl phosphonamidates and acyl benzylamines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer External link
Filling date: 8 Sep 2025 Issue date: 7 Jul 2020
Grant
Utility: Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer External link
Filling date: 8 Sep 2025 Issue date: 23 Jun 2020
Grant
Utility: Technology to inhibit vascular changes that lead to vision loss in the eye External link
Filling date: 8 Sep 2025 Issue date: 17 Mar 2020
Grant
Utility: Composition comprising a gene vector that selectively depletes P16 positive senescent cells External link
Filling date: 8 Sep 2025 Issue date: 4 Feb 2020
Grant
Utility: Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer External link
Filling date: 8 Sep 2025 Issue date: 31 Dec 2019
Grant
Utility: Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor External link
Filling date: 8 Sep 2025 Issue date: 31 Dec 2019
Grant
Utility: Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss External link
Filling date: 8 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye External link
Filling date: 8 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Chemical entities that kill senescent cells for use in treating age-related disease External link
Filling date: 8 Sep 2025 Issue date: 1 Oct 2019
Grant
Utility: Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase External link
Filling date: 8 Sep 2025 Issue date: 17 Sep 2019
Grant
Utility: Replication conditional virus that specifically kills senescent cells External link
Filling date: 8 Sep 2025 Issue date: 13 Aug 2019

Showing 1 to 17 of 17 patents.